The Egyptian Heart Journal, published by Springer, is a premier open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. As of 2023, it holds a Q3 classification within the category, showcasing its growing influence within the research community, and ranks 241 out of 387 in Scopus, reflecting a 37th percentile position. With an E-ISSN of 2090-911X, this journal has been open access since 2011, making it easily accessible to researchers, practitioners, and students alike. The journal aims to disseminate high-quality research articles, reviews, and case studies that contribute to the understanding and treatment of cardiovascular diseases. With its focus on innovative and practical solutions in cardiology, the Egyptian Heart Journal plays a critical role in shaping current and future cardiovascular research. Its global outreach and commitment to open access ensure that vital information is available to a wide audience, enhancing both scholarly discourse and clinical practice in the evolving landscape of cardiovascular medicine.

NEUROLOGIC CLINICS, published by W B SAUNDERS CO-ELSEVIER INC, stands as a leading journal in the field of clinical neurology, boasting an impressive impact factor that reflects its significant contributions to neurological research and clinical practice. With an ISSN of 0733-8619 and E-ISSN of 1557-9875, this journal provides a critical platform for the dissemination of innovative research, case studies, and reviews focusing on various aspects of neurology, from diagnosis to treatment interventions. As part of its commitment to advancing the understanding of neurological disorders, NEUROLOGIC CLINICS is categorized in the Q2 quartile for Neurology (clinical) in 2023, indicating its robust standing within the academic community. It is recognized for its rigorous peer-review process and is indexed in Scopus, ranking #147 out of 400 in its field with a notable 63rd percentile. The journal, which dates back to 1983 and continues to publish vital findings up to 2024, is an invaluable resource for researchers, healthcare professionals, and students dedicated to enhancing their knowledge and clinical skills in neurology. Subscribe now to stay abreast of current advancements and expand your expertise in this dynamic field.

Stroke Research and Treatment is a premier Open Access journal published by HINDAWI LTD, dedicated to advancing the understanding and management of stroke and related neurological disorders. Since its inception in 2010, this journal has established itself as a valuable resource for researchers and clinicians in the field of neurology, providing a platform for high-quality, peer-reviewed articles that aim to improve patient outcomes and stimulate clinical practice innovations. With a 2023 Scopus ranking placing it in the Q3 category and a percentile ranking of 44th in clinical neurology, the journal is positioned to influence the ongoing discourse in stroke research. Stroke Research and Treatment embraces a global audience, with its editorial operations based in London, England. The journal's commitment to open access ensures that its content is freely available to all, promoting extensive dissemination and engagement in this critical field of study. Researchers, professionals, and students are encouraged to contribute their findings to this dynamic journal, fostering collaboration and knowledge sharing in the ongoing fight against stroke.

Stroke and Vascular Neurology is a premier open access journal published by BMJ PUBLISHING GROUP, dedicated to advancing the field of vascular neurology and cardiology. With an ISSN of 2059-8688 and an E-ISSN of 2059-8696, the journal has established itself as a leading platform for disseminating cutting-edge research since its transition to open access in 2016. Based in the United Kingdom, at BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND, the journal's outstanding reputation is reflected in its Q1 rankings in both Cardiology and Cardiovascular Medicine and Neurology (clinical) for 2023, placing it in the top tier of its categories. With Scopus rankings of 28 out of 387 in Cardiology and 30 out of 400 in Neurology (clinical), both within the 92nd percentile, Stroke and Vascular Neurology serves as an essential resource for researchers, clinicians, and students looking to stay at the forefront of advancements in the management and understanding of stroke-related disorders. The journal's commitment to high-quality research contributes significantly to improving patient outcomes and shaping the future of vascular health.

Journal of Neurologic Physical Therapy, published by Lippincott Williams & Wilkins, stands as a premier resource in the field of physical therapy with a specific focus on neurology. With an ISSN of 1557-0576 and an E-ISSN of 1557-0584, this journal serves as a vital platform for researchers, practitioners, and students from 2004 to 2024, illustrating its commitment to advancing knowledge in neurologic rehabilitation. It holds a prestigious Q1 ranking in categories such as Physical Therapy, Sports Therapy, and Rehabilitation and Rehabilitation, alongside Q2 rankings in Geriatrics and Gerontology, Medicine (Miscellaneous), and Neurology (Clinical). With an impact factor that reflects its significance, the journal hosts comprehensive studies and clinical insights that propel practice and innovation in neurologic physical therapy. The content is designed to enhance understanding and skills, making it an indispensable resource for those dedicated to improving patient care and outcomes in this critical area of health.

Translational Stroke Research, published by Springer, stands at the forefront of the intersection of cardiology, neurology, and neuroscience, specifically focusing on the latest advancements in stroke research from 2010 to 2024. With an impressive impact factor as evidenced by its Q1 rankings in Cardiology and Cardiovascular Medicine, Clinical Neurology, and Neuroscience, this journal is a vital resource for researchers, clinicians, and students alike. It holds significant recognition in the academic community, achieving notable rankings in Scopus, including 15th out of 387 in Cardiology and 17th out of 400 in Clinical Neurology, showcasing its impact and relevance in these critical fields. Although not an open-access journal, it provides access options through institutional subscriptions, thereby facilitating the sharing of influential research that has the potential to shape the mitigation and understanding of stroke and related conditions. Researchers and practitioners seeking to expand their knowledge and engage with cutting-edge findings will find Translational Stroke Research to be an indispensable addition to their scholarly resources.

ONCOLOGY is a prestigious journal published by KARGER, dedicated to advancing the field of cancer research and treatment. Established in 1948, this peer-reviewed journal has established a significant presence in the medical community, reflected by its impressive impact factor and Q2 category rankings in both Cancer Research and Oncology as of 2023. With a focus on groundbreaking research and comprehensive reviews, ONCOLOGY serves as a crucial resource for researchers, clinicians, and students interested in the latest developments in the fight against cancer. Although it currently does not offer open access, the journal's reputation ensures that it reaches a wide audience in academia and clinical practice. Its commitment to excellence is underscored by its consistent rankings in key disciplines, making it a vital publication for anyone involved in cancer research, biology, or associated medical fields. The journal is headquartered in Basel, Switzerland, positioning it at the heart of European medical research.

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

Brain Circulation, published by Wolters Kluwer Medknow Publications, is a premier open-access journal dedicated to advancing knowledge and research in the field of neurovascular health and brain circulation. Since its inception in 2015, this journal has played a pivotal role in disseminating high-quality research articles, reviews, and case studies that explore the intricate relationship between cerebrovascular dynamics and neurological disorders. The journal is committed to fostering a collaborative environment for global researchers, healthcare professionals, and students, aiming to improve outcomes in neuroprotection and treatment strategies. Although it does not currently have an H-index listed, its focus on innovative research ensures its growing significance within the academic community. With a user-friendly open-access model, Brain Circulation invites contributions that enhance understanding and reshape practices in neurovascular care, making it an essential resource for those dedicated to unraveling the complexities of brain health.

ACTA NEUROLOGICA SCANDINAVICA is a prestigious journal published by Wiley that has significantly contributed to the field of neurology and neuroscience since its inception in 1961. With a broad scope encompassing clinical and experimental research, this journal is esteemed for its rigorous peer-review process and high-quality publications. Located in the United Kingdom, it is recognized in the 2023 category quartiles as Q1 in Medicine (miscellaneous) and Q2 in both Neurology and Clinical Neurology, indicating its strong influence and relevance within the medical community. With an H-index demonstrating consistent citation impact, ACTA NEUROLOGICA SCANDINAVICA holds a Scopus rank of #86 out of 400 in Clinical Neurology, reflecting its contribution to advancing current knowledge and practice. Researchers, professionals, and students alike will find in this journal a valuable resource for the latest findings, discussions, and developments in understanding neurological disorders and treatments, furthering educational and clinical endeavors alike.